2005
DOI: 10.1007/3-540-28621-7
|View full text |Cite
|
Sign up to set email alerts
|

Gap Junctions in Development and Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(2 citation statements)
references
References 454 publications
(809 reference statements)
0
2
0
Order By: Relevance
“…and EL2 C(1)zzzvC( 2)vzzvvC(3) sequences, in which 100 % of C(1), C(2), C(3), >80 % of X residues (v) and <80 % of X residues (z) are conserved 58 . In view of conserved extracellular cysteines and extensively homologous protein sequences of Cx isoforms, along with their mutations, phosphorylated and ubiquitinated derivatives 43,44,47,92,93 , it seems likely that several homo-and heteromeric CxGJ . CC-BY-ND 4.0 International license made available under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.…”
Section: Spatio-temporal Configuration Dynamics Of Paired Cx43hc-hc M...mentioning
confidence: 99%
See 1 more Smart Citation
“…and EL2 C(1)zzzvC( 2)vzzvvC(3) sequences, in which 100 % of C(1), C(2), C(3), >80 % of X residues (v) and <80 % of X residues (z) are conserved 58 . In view of conserved extracellular cysteines and extensively homologous protein sequences of Cx isoforms, along with their mutations, phosphorylated and ubiquitinated derivatives 43,44,47,92,93 , it seems likely that several homo-and heteromeric CxGJ . CC-BY-ND 4.0 International license made available under a (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.…”
Section: Spatio-temporal Configuration Dynamics Of Paired Cx43hc-hc M...mentioning
confidence: 99%
“…GJ channels have received attention due to their pivotal roles in various physiological and pathophysiological processes [38][39][40][41][42][43][44][45][46][47][48][49][50][51] , such as epilepsy 52 , Alzheimer disease 53 or cancer [54][55][56] . However, the lack of Cx subtype-specific inhibitors for these channels has hindered their exploitation in pharmacological strategies.…”
Section: Introductionmentioning
confidence: 99%